GH replacement does not increase the risk of recurrence in patients with craniopharyngioma (Q48560324)

12 February 2018

title

GH replacement does not increase the risk of recurrence in patients with craniopharyngioma (English)

1 reference

12 February 2018

1 reference

6

1 reference

12 February 2018

Niki Karavitaki

object named as

Niki Karavitaki

1

0 references

John A H Wass

8

object named as

John A H Wass

1 reference

12 February 2018

author name string

Justin T Warner

2

1 reference

12 February 2018

Anne Marland

3

1 reference

12 February 2018

Brian Shine

4

1 reference

12 February 2018

Fiona Ryan

5

1 reference

12 February 2018

Helen E Turner

7

1 reference

12 February 2018

publication date

1 May 2006

1 reference

12 February 2018

published in

Clinical Endocrinology

1 reference

12 February 2018

volume

64

1 reference

12 February 2018

issue

5

1 reference

12 February 2018

page(s)

556-560

1 reference

12 February 2018

Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Correlation of clinical and pathological features in surgically treated craniopharyngiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Long-term experience with GH replacement therapy: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Growth hormone treatment induces mammary gland hyperplasia in aging primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Cancer risk following growth hormone use in childhood: implications for current practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Long-term outcomes for surgically resected craniopharyngiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

20-year experience in childhood craniopharyngioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Craniopharyngioma--a long-term results following limited surgery and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

CRANIOPHARYNGIOMA RECURRENCE AND GROWTH HORMONE THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Adverse events during growth hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

10.1111/J.1365-2265.2006.02508.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018